Cover Image
市場調查報告書

臨床化學分析設備市場:分析與各市場區隔的預測

Clinical Chemistry Analyzers Market Analysis By Product (Analyzers, Reagents), By Test (BMP, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Profile, Specialty Chemical Tests), By End Use, & Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 478659
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床化學分析設備市場:分析與各市場區隔的預測 Clinical Chemistry Analyzers Market Analysis By Product (Analyzers, Reagents), By Test (BMP, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Profile, Specialty Chemical Tests), By End Use, & Segment Forecasts, 2014 - 2025
出版日期: 2017年02月21日 內容資訊: 英文 100 Pages
簡介

本報告提供全球臨床化學分析設備市場相關調查分析,提供概要,各市場區隔預測,加上競爭情形,主要企業等系統性資訊。

第1章 調查手法·範圍

第2章 摘要整理

第3章 臨床化學分析設備市場:變數·趨勢·範圍

  • 市場區隔·範圍
  • 推動市場要素分析
  • 阻礙市場要素分析
  • 普及率·成長預測製圖
  • SWOT分析
  • 波特的五力分析

第4章 臨床化學分析設備市場:各產品預測·趨勢分析

  • 各產品趨勢分析
  • 分析設備
  • 試劑
  • 其他

第5章 臨床化學分析設備市場:檢查別預測·趨勢分析

  • 檢查別趨勢分析
  • 代謝
  • 特殊化學物質
  • 甲狀腺功能
  • 脂質
  • 電解質
  • 肝臟
  • 腎臟

第6章 臨床化學分析設備市場:各最終用途預測·趨勢分析

  • 各最終用途趨勢分析
  • 醫院
  • 學術研究中心
  • 臨床檢驗室
  • 其他

第7章 臨床化學分析設備市場:各地區的預測·趨勢分析

  • 各地區的市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭情形

  • 策略性組成架構
  • 市場參與企業的類別化
  • 企業簡介
    • Mindray Medical International Limited
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Abbott Laboratories
    • Johnson & Johnson
    • Siemens AG
    • F.Hoffmann-La Roche Ltd.
    • Elitech Group
    • 堀場製作所
    • Randox Laboratories
目錄
Product Code: GVR-1-68038-409-3

The global clinical chemistry analyzers market is expected to reach USD 16.0 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth.

Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand.

Further Key Findings From the Study Suggest:

  • Reagents held a substantial share in product segment in 2015. The substantial share can be attributed to increasing reagent rental agreements and availability resulting in quick global access
  • Lipid panel is anticipated to exhibit lucrative CAGR during the forecast period owing to increasing adoption, as the demand for screening tests for cholesterol and triglyceride levels in case of cardiovascular disorders and diabetes has increased
  • In 2016, North America accounted for substantial share in the global clinical chemistry analyzers market, as a consequence of local presence of prominent companies involved in high R&D investments
  • Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgradation, and growing healthcare expenditure
  • Some key participants such as Mindray Medical International Ltd.; Johnson & Johnson; and F.Hoffmann-La Roche Ltd. are undertaking various sustainability strategies, such as new product development & frequent product approvals, to gain competitive advantage
  • For instance, in August 2016, Mindray announced the premarket FDA clearance for Mindray BA-800M clinical chemistry analyzer allowing it to distribute its product

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region-wise market: Base estimates
    • 1.1.2 Global market: CAGR calculation
  • 1.2 Region-Based Segment Share Calculation
  • 1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Clinical Chemistry Analyzers Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
  • 3.3 Market Restraint Analysis
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Clinical Chemistry Analyzers Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 3.6 Industry Analysis - Porter's

Chapter 4 Clinical Chemistry Analyzers Market: Product Estimates & Trend Analysis

  • 4.1 Clinical Chemistry Analyzers Market: Product Movement Analysis
  • 4.2 Analyzers
    • 4.2.1 Analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.2 Small analyzers
      • 4.2.2.1 Small analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.3 Medium analyzers
      • 4.2.3.1 Medium analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.4 Large analyzers
      • 4.2.4.1 Large analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.5 Very large analyzers
      • 4.2.5.1 Very large analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3 Reagents
    • 4.3.1 Reagents market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.2 Calibrators
      • 4.3.2.1 Calibrators market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.3 Controls
      • 4.3.3.1 Controls market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.4 Standards
      • 4.3.4.1 Standards market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.4 Others
    • 4.4.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Clinical Chemistry Analyzers Market: Test Estimates & Trend Analysis

  • 5.1 Clinical Chemistry Analyzers Market: Test Movement Analysis
  • 5.2 Metabolic Panels
    • 5.2.1 Metabolic panels market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.3 Specialty Chemical Tests
    • 5.3.1 Specialty chemical tests market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.4 Thyroid Function Tests
    • 5.4.1 Thyroid function tests market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.5 Lipid Profiles
    • 5.5.1 Lipid profiles market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.6 Electrolyte Panels
    • 5.6.1 Electrolyte panels market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.7 Liver Panels
    • 5.7.1 Liver panels market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.8 Renal Profiles
    • 5.8.1 Renal profiles market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Clinical Chemistry Analyzers Market: End-Use Estimates & Trend Analysis

  • 6.1 Clinical Chemistry Analyzers Market: End-Use Movement Analysis
  • 6.2 Hospitals
    • 6.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Million)
  • 6.3 Academic Research Centers
    • 6.3.1 Academic research centers market estimates and forecasts, 2014 - 2025 (USD Million)
  • 6.4 Diagnostic Laboratories
    • 6.4.1 Diagnostic laboratories market estimates and forecasts, 2014 - 2025 (USD Million)
  • 6.5 Others
    • 6.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 7 Clinical Chemistry Analyzers Market: Regional Estimates & Trend Analysis, by Product, Test & End-Use

  • 7.1 Clinical Chemistry Analyzers Market Shares by Region, 2016 & 2025
  • 7.2 North America
    • 7.2.1 North America clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.3.3 UK
      • 7.3.3.1 UK clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa clinical chemistry analyzers market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Market Participation Categorization
  • 8.3 Company Profiles
    • 8.3.1 Mindray Medical International Limited
      • 8.3.1.1 Company overview
      • 8.3.1.2 Financial performance
      • 8.3.1.3 Geographic foothold
      • 8.3.1.4 Product benchmarking
      • 8.3.1.5 Strategic initiatives
    • 8.3.2 Thermo Fisher Scientific Inc.
      • 8.3.2.1 Company overview
      • 8.3.2.2 Financial performance
      • 8.3.2.3 Geographic foothold
      • 8.3.2.4 Product benchmarking
      • 8.3.2.5 Strategic initiatives
    • 8.3.3 Danaher Corporation
      • 8.3.3.1 Company overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Geographic Foothold
      • 8.3.3.4 Product benchmarking
      • 8.3.3.5 Strategic initiatives
    • 8.3.4 Abbott Laboratories
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Geographic foothold
      • 8.3.4.4 Product benchmarking
      • 8.3.4.5 Strategic initiatives
    • 8.3.5 Johnson & Johnson
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial performance
      • 8.3.5.3 Geographic foothold
      • 8.3.5.4 Product benchmarking
      • 8.3.5.5 Strategic initiatives
    • 8.3.6 Siemens AG
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Geographic foothold
      • 8.3.6.4 Product benchmarking
      • 8.3.6.5 Strategic initiatives
    • 8.3.7 F.Hoffmann-La Roche Ltd.
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Financial Performance
      • 8.3.7.3 Geographic foothold
      • 8.3.7.4 Product benchmarking
      • 8.3.7.5 Strategic initiatives
    • 8.3.8 Elitech Group
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Financial Performance
      • 8.3.8.3 Geographic foothold
      • 8.3.8.4 Product benchmarking
      • 8.3.8.5 Strategic initiatives
    • 8.3.9 Horiba, Ltd.
      • 8.3.9.1 Company overview
      • 8.3.9.2 Financial performance
      • 8.3.9.3 Geographic foothold
      • 8.3.9.4 Product benchmarking
      • 8.3.9.5 Strategic initiatives
    • 8.3.10 Randox Laboratories
      • 8.3.10.1 Company overview
      • 8.3.10.2 Financial performance
      • 8.3.10.3 Geographic foothold
      • 8.3.10.4 Product benchmarking
      • 8.3.10.5 Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 3 North America clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 4 North America clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 5 U.S. clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 6 U.S. clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 7 U.S. clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 8 Canada clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 9 Canada clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 10 Canada clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 11 Europe clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 12 Europe clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 13 Europe clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 14 Germany clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 15 Germany clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 16 Germany clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 17 UK clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 18 UK clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 19 UK clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 20 Asia Pacific clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 21 Asia Pacific clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 22 Asia Pacific clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 23 Japan clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 24 Japan clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 25 Japan clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 26 China clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 27 China clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 28 China clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 29 India clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 30 India clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 31 India clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 32 Latin America clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 33 Latin America clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 34 Latin America clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 35 Brazil clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 36 Brazil clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 37 Brazil clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 38 Mexico clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 39 Mexico clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 40 Mexico clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 41 MEA clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 42 MEA clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 43 MEA clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)
  • TABLE 44 South Africa clinical chemistry analyzers market, by product, 2014 - 2025 (USD Million)
  • TABLE 45 South Africa clinical chemistry analyzers market, by test, 2014 - 2025 (USD Million)
  • TABLE 46 South Africa clinical chemistry analyzers market, by end use, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market summary (USD Million)
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 SWOT analysis, by factor (Political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Clinical chemistry analyzers market product outlook key takeaways
  • FIG. 10 Clinical chemistry analyzers market: Product movement analysis
  • FIG. 11 Global analyzers market, 2014 - 2025 (USD Million)
  • FIG. 12 Global small analyzers market, 2014 - 2025 (USD Million)
  • FIG. 13 Global medium analyzers market, 2014 - 2025 (USD Million)
  • FIG. 14 Global large analyzers market, 2014 - 2025 (USD Million)
  • FIG. 15 Global small analyzers market, 2014 - 2025 (USD Million)
  • FIG. 16 Global reagents market, 2014 - 2025 (USD Million)
  • FIG. 17 Global calibrators market, 2014 - 2025 (USD Million)
  • FIG. 18 Global controls market, 2014 - 2025 (USD Million)
  • FIG. 19 Global standards market, 2014 - 2025 (USD Million)
  • FIG. 20 Global others market, 2014 - 2025 (USD Million)
  • FIG. 21 Global others market, 2014 - 2025 (USD Million)
  • FIG. 22 Clinical chemistry analyzers market test outlook: Key takeaways
  • FIG. 23 Clinical chemistry analyzers market: Test movement analysis
  • FIG. 24 Global metabolic panels market, 2014 - 2025 (USD Million)
  • FIG. 25 Global specialty chemical tests market, 2014 - 2025 (USD Million)
  • FIG. 26 Global thyroid function tests market, 2014 - 2025 (USD Million)
  • FIG. 27 Global lipid profiles market, 2014 - 2025 (USD Million)
  • FIG. 28 Global electrolyte panels market, 2014 - 2025 (USD Million)
  • FIG. 29 Global liver panels market, 2014 - 2025 (USD Million)
  • FIG. 30 Global renal profiles market, 2014 - 2025 (USD Million)
  • FIG. 31 Clinical chemistry analyzers market end use outlook: Key takeaways
  • FIG. 32 Clinical chemistry analyzers market: End-use movement analysis
  • FIG. 33 Global hospitals market, 2014 - 2025 (USD Million)
  • FIG. 34 Global academic research centers market, 2014 - 2025 (USD Million)
  • FIG. 35 Global diagnostic laboratories market, 2014 - 2025 (USD Million)
  • FIG. 36 Global others market, 2014 - 2025 (USD Million)
  • FIG. 37 Regional market place: Key takeaways
  • FIG. 38 Regional outlook, 2016 & 2025
  • FIG. 39 North America clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 40 U.S. clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 41 Canada clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 42 Europe clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 43 Germany clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 44 UK clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 45 Asia Pacific clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 46 Japan clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 47 China clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 48 India clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 49 Latin America clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 50 Brazil clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 51 Mexico clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 52 MEA clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 53 South Africa clinical chemistry analyzers market, 2014 - 2025 (USD Million)
  • FIG. 54 Strategy framework
  • FIG. 55 Participant categorization
Back to Top